This company listing is no longer active
Salud financiera de hoja de balance de Solgenics
Salud financiera controles de criterios 1/6
Solgenics has a total shareholder equity of $13.0M and total debt of $5.7M, which brings its debt-to-equity ratio to 44.1%. Its total assets and total liabilities are $19.0M and $6.0M respectively.
Información clave
44.1%
Ratio deuda-patrimonio
US$5.73m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$436.00k |
| Patrimonio | US$12.99m |
| Total pasivo | US$6.04m |
| Activos totales | US$19.03m |
Actualizaciones recientes sobre salud financiera
Análisis de la situación financiera
Pasivos a corto plazo: SGN's short term assets ($510.0K) do not cover its short term liabilities ($6.0M).
Pasivo a largo plazo: SGN has no long term liabilities.
Historial y análisis de deuda-patrimonio
Nivel de deuda: SGN's net debt to equity ratio (40.8%) is considered high.
Reducción de la deuda: SGN's debt to equity ratio has increased from 17.9% to 44.1% over the past 5 years.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: Insufficient data to determine if SGN has enough cash runway based on its current free cash flow.
Pronóstico de cash runway: Insufficient data to determine if SGN has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.